熱門資訊> 正文
SHL远程医疗报告财年业绩
2024-04-17 17:18
- SHL Telemedicine press release (NASDAQ:SHLT): FY Net loss was $6.9m, compared to a net loss of $0.4M in FY2022.
- Revenue of $57.1M (+3.1% Y/Y).
- Adjusted EBITDA for the company was $2.1M, compared to $3.5M in 2022.
- Cash on hand and short-term cash investments as of December 31, 2023, remain robust at $26M
More on SHL Telemedicine
- Seeking Alpha’s Quant Rating on SHL Telemedicine
- Historical earnings data for SHL Telemedicine
- Financial information for SHL Telemedicine
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
